InstructorRoyed Training
TypeOnline Course
Price$250 / 13750 INR.
Buy NowBook Now
Pharma Pricing Reimbursement


Who should attend


Course Deliverable


Related Courses

About PPR

Pharma Pricing Reimbursement Training course

This course will provide practical understanding about the health economics, pharma pricing and reimbursement.

This advanced online pricing course covers pharmaceutical and biopharmaceutical market access strategic management and planning process. Hence, this course will demonstrate pricing management skills who worked in market access and pricing field. There are no doubt of the fact pricing plays important role in pharmaceutical and biopharmaceutical organization to success. Hence, this course provides real life case based simulations for better understanding the complex issues of health economics and pricing. As a result, it is easy for participants to understand the concepts. Moreover, cutting edge simulations help participants apply the knowledge in interactive real life simulation.

Above all, this pricing reimbursement training course focus on value pricing for market access which is important critical yet complex buzzword in biopharmaceutical industry. Also at the same time, course provides in-depth understanding on evidence-based pricing for pharmaceuticals. 

In addition, this course challenges students and Professionals to apply what they have learned through the use of interactive exercises, reflection questions, and a final assessment at the end of the course.

The course can be completed at any place. So, it allows the user to stop and start at their leisure. Moreover, user can access the course at own pace. It allows the user to stop and start at their leisure. 

Course Snapshot

  • Course Code: RYD-111
  • Title of the Course: Competency Development Training on Pharma Pricing and Reimbursement (ACPPR)
  • Nature of the course: Online distance learning course. Course can be accessed online across anywhere 24×7.
  • Duration: 1 Week
  • Course Certificate: Certificate will be provided at the end of the successful completion of the course

Who should attend?

  • Pricing, Market Access Professionals who want to learn about regional markets.
  • Regulatory professionals who want to learn about commercial issues.
  • Strategic planners who want to know where they might go next
  • Those who want insight into the way that markets influence each other.
  • Anyone who wants to understand global pricing issues.

Graduation in any discipline.

  1. Attend the course 24×7 by login to your dashboard. Therefore, one can attend lectures, simulation, self assessment tests and final certification examination online at own convenience.
  2. You will also be eligible to receive the course study modules, which you can download by login to your course page.

Course Features

This online course utilizes 24×7 interactive learning tools to guide each participant through the steps of market access, pricing, forecasting and reimbursement. Moreover this market access training challenges participants to apply what they have learned through the use of interactive exercises, reflection questions, expert live chat and a final assessment at the end of the course.

Important Learning Features: 

  • Online 24×7 access from anywhere. Hence, one can learn at your convenience.
  • The course provides timing flexibility. In other words, one can attend the lecture sessions at your own convenient time.
  • The course is build on interactive e-learning. Hence, it helps user to understand of the concepts effectively.
  • Above all, course provides simulation for real life working. Hence, it helps user to apply the decision making skill in real life scenarios.

Course Coverage Area

  • The course provided comprehensive advanced understanding on global and national pricing, market access, pricing, forecasting.
  • Advance practical training in health economics and evidence based pricing concepts.
  • Advance training on market assessment to determine pricing models.
  • Detailed training on forecasting models and techniques with practical case studies.
  • Training on value dossier preparation.
  • Health Economics.
  • Health Technology Assessments.
  • Patient Advocacy.

Related Courses

At Royed Training, we have 1 year PG Cortication in Pharma Market Access.

Followings are the few of the similar courses, you may be interested in

  • Pharma Market Access and Pricing >> Click here
  • Pharma Global Management >> Click here
  • Biopharma Global Business Course >> Click here
  • Drug Regulatory Affairs Course >> Click here
  • Online Training on CE certification >> Click here
  • Medical devices regulatory affairs >> Click here
  • Drug, Biologic and Medical Devices Regulatory Affairs Course >> Click here
  • USFDA Pharmaceutical and Biopharmaceutical Regulatory Affairs >> Click here

PPR – Pharma Pricing and Reimbursement

Pharmaceutical pricing and reimbursement are complex topics that involve government policies, insurance systems, pharmaceutical companies, healthcare providers, and patients. These elements vary significantly from country to country, making it essential to consider the specific context in which pharmaceuticals are priced and reimbursed. Here’s a general overview of these concepts:

Pharmaceutical Pricing: Pharmaceutical pricing refers to the cost set by pharmaceutical manufacturers for their drugs and medications. Several factors influence drug pricing:

  1. Research and Development Costs: The expenses incurred during drug development, including clinical trials, play a significant role in determining drug prices.
  2. Production and Manufacturing Costs: The cost of producing and manufacturing the drug affects its pricing. This includes the cost of raw materials, labor, and facilities.
  3. Competition: The level of competition in the market for a particular drug can impact pricing. In markets with multiple similar drugs (generic competition), prices tend to be lower.
  4. Market Demand: The demand for a drug and its therapeutic benefits can influence pricing. Drugs for rare diseases or life-threatening conditions may be priced higher.
  5. Regulatory and Patent Protection: Pharmaceutical companies often hold patents that grant them exclusive rights to sell a drug for a certain period. This exclusivity can allow them to set higher prices.
  6. Government Regulations: Different countries have various regulations that affect drug pricing. Some countries regulate prices directly, while others negotiate prices with pharmaceutical companies.

Pharmaceutical Reimbursement: Reimbursement involves how the costs of pharmaceuticals are covered, either by public or private health insurance systems, or out-of-pocket payments by patients. Key factors in pharmaceutical reimbursement include:

  1. Healthcare Systems: The structure of a country’s healthcare system, whether it’s public, private, or a mix of both, impacts how pharmaceuticals are reimbursed.
  2. Health Insurance: Health insurance plans, whether provided by the government or private insurers, determine how much of a drug’s cost is covered for the patient.
  3. Formularies: Many health insurance plans have formularies, which are lists of approved drugs. Drugs not on the formulary may not be reimbursed, or they may have higher patient copayments.
  4. Cost-Sharing: Patients may be required to pay a portion of the drug’s cost, such as copayments or deductibles, when they obtain prescription medications.
  5. Government Programs: In some countries, government programs like Medicaid in the United States or the National Health Service (NHS) in the UK, provide healthcare coverage, including reimbursement for pharmaceuticals.
  6. Price Negotiations: In some countries, governments negotiate directly with pharmaceutical companies to set drug prices, aiming to control healthcare costs.
  7. Pharmaceutical Benefit Management: Organizations may be involved in managing drug benefits for insurers and employers, influencing which drugs are covered and how they are reimbursed.

This course on Pharmaceutical pricing and reimbursement policies provides brainstorming sessions on healthcare costs, access to medications, and the financial sustainability of healthcare systems. Most importantly course ensures understanding on how how to manage the Governments, healthcare providers, pharmaceutical companies, and patients to ensure safe access to essential medications and controlling healthcare expenditures.

Section 1Core Learning Topics: Market Access, Pharamcoeconomics, Pricing and Reimbursement - Fundamental Understanding
Lecture 1Introduction to Market Access | Objectives | Various Key Terminologies | Steps of Market Access | Understanding on Pricing and Reimbursement
Lecture 2Market Access Functions : Role and Responsibilities | Key Job Areas | Understanding Job Description
Lecture 3Market Access Strategic Planning : Steps and Logical Sequencing for Market Access Strategy Development
Lecture 4Indication Sequencing | Indication Prioritization | Development of Indication Timeline | Indication Matrix | Value Based Indication Prioritization
Lecture 5Indication Prioritization Case Study
Lecture 6Market Access Value Dossier : What it is | Significance | Components | What to include
Lecture 7AMCP Market Access Dossier Preparation 
Lecture 8Target product profile (TPP) | Quality Target product profile (QTPP) | Critical Quality Attributes (CQAs) | Quality By Design (QbD)
Lecture 9First-in-class | Best-in-class | Market Access Strategic Decision Making 
Lecture 10Introduction to Health Economics | Key terminologies related to health economics
Lecture 11HEOR Application in Pharmaceutical and Biopharmaceutical Industry
Lecture 12Introduction to Pharmacoeconomics | Different Types of Economic Evaluation | Cost-effectiveness plane | Economic modeling |Sensitivity Analysis | One way sensitivity analysis | Probabilistic sensitivity analysis 
Lecture 13Economic Evaluation Methods | Various methods | Importance of perspective in health economics | Discounting | Uncertainty 
Lecture 14Core fundamentals of Health Economics | Clinical and economic burden | Public Health Care Payer Vs. Patient and Societal | Positioning a new treatment with the current treatment | QALY | ICER | Threshold value | Clinical trials vs health economics assessment
Lecture 15Pharmacoeconomic Evaluation Checklist | Health Economics Map | Economic evaluation cycle | Checklist of economic evaluation | Costs and Outcome relevant to different groups | Comparators | Problem of choosing the comparators
Lecture 16Pharmacoeconomic Evaluation - Resource and Cost | Fixed, Variable and Total Cost | Calculation | Average vs. marginal cost | Importance of marginal cost | Discounting | Discounting calculation | Preferable discounting rate | Sources of unit cost data | Reference costs
Lecture 17Pharmacoeconomic Evaluation - Benefits and Outcome | C/E Ratio | Intermediate Vs. Final Outcome | Sources of Effectiveness Data | QALY | Utility Weight | WTP | VPF | ATP | Difference between WTP & ATP 
Lecture 18Pharmaco-economic evaluation – analysis and results | Different Types of Models | Understanding Decision Tree - Components with practical Example | Markov model 
Lecture 19CER and PCOR
Lecture 20QALY | How to calculate QALY | Importance and Significance 
Lecture 21ICER | How to calculate ICER | Importance and Significance | Incremental Effectiveness determination 
Lecture 22Evidence Based Decision Making | Combine evidences for decision making | Do we need more evidence? 
Lecture 23RWD and RWE | Potential sources of RWE | Traditional RCTs vs. RWE | Case Study - RWE Programs | Influencing HCP decision-making
Lecture 24RWD and RWE in Product Lifecycle Management
Lecture 25RWD and RWE - Fit to use | Assessment
Lecture 26RWD data sources | Different types | Detailed understanding of each class 
Lecture 27Drug Pricing Methodologies I
Lecture 28Drug Pricing Methodologies II
Lecture 29Formulary Placement | Different Tiers | How to classify the medication in different tiers | Formulary negotiation process | Rebates | Copay differential | Step-edits | Case Simulations - teasers
Lecture 30Pharma Market Access Pricing Case Study : Interchangeable Pricing 
Lecture 31Rebates | Importance | Factors affecting Rebates | Deductibles and Rebates
Lecture 32Medicare | Medicaid | Medigap | Different plans | Related Terminologies| Advanced training on Medicare Part D
Lecture 33Pharma Market Access Pricing Case Study : Interchangeable Pricing 
Section 2Request for Course Certificate